Clinical Trials on Primary Sjögren's Syndrome Painful Sensory Neuropathies

Total 180 results

University Hospital, Strasbourg, France

Recruiting

Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies (TINISS)

Primary Sjögren's Syndrome Painful Sensory Neuropathies

France
University Of Perugia

Unknown

Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome

Painful Bladder Syndrome (PBS)

Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
Peking University People's Hospital

Recruiting

Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome

Primary Sjögren's Syndrome

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Assistance Publique - Hôpitaux de Paris
Societe Francaise de Rhumatologie

Recruiting

The ASSESS National Multi-center Prospective Cohort (ASSESS)

Primary Sjögren's Syndrome

France
Senyue Zhang

Completed

Acupuncture Combined With Hydroxychloroquine

Primary Sjögren's Syndrome

China
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
RemeGen Co., Ltd.

Completed

A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
University Hospital, Strasbourg, France

Completed

Efficacy of Tocilizumab in Primary Sjögren's Syndrome. (ETAP)

Primary Sjögren's Syndrome (pSS)

France
National Institute of Allergy and Infectious Diseases...
Biogen; Autoimmunity Centers of Excellence

Terminated

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Primary Sjögren's Syndrome

United States
Novartis Pharmaceuticals

Withdrawn

Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome
argenx
Iqvia Pty Ltd

Completed

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (rho)

Primary Sjögren's Syndrome

Belgium, Poland, Hungary, Netherlands
Bristol-Myers Squibb

Terminated

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome

Healthy Participants | Primary Sjögren's Syndrome

Germany, United States
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

Hungary, Germany
UCB Celltech
PRA Health Sciences

Terminated

UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

France, Italy, Spain, Sweden, United Kingdom
MedImmune LLC
Amgen

Completed

A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Sweden, France, United Kingdom
University Hospital, Limoges

Completed

Primary Sjögren Syndrome (NeuroSenSS)

Primary Sjögren's Syndrome

France
University Hospital, Brest

Recruiting

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort (DIApSS)

Primary Sjögren's Syndrome (pSS)

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity (I GET DRY)

Primary Sjögren's Syndrome

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Primary Sjögren's Syndrome

United States, France, United Kingdom, Australia, Germany, Hungary, Spain
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome (pSS)

Korea, Republic of
Novartis Pharmaceuticals

Completed

PD of VAY736 in Patients With Primary Sjögren's Syndrome (CVAY736X2201)

Primary Sjögren's Syndrome

Germany
Incyte Corporation

Completed

A Study of INCB050465 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Hungary, Germany, Switzerland, United Kingdom
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Assistance Publique - Hôpitaux de Paris
Sanofi

Completed

Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome (JOQUER)

Primary Sjögren's Syndrome

France
Gazi University

Not yet recruiting

The Profile of Fatigue and Discomfort - Sicca Symptoms Inventory

Primary Sjögren's Syndrome

Turkey
Case Western Reserve University

Not yet recruiting

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Interstitial Cystitis | Painful Bladder Syndrome (PBS)
ETH Zurich
Neural Control of Movement laboratory ETH Zurich

Recruiting

multiSENSory Stimulation to tArgeT Sensory Loss and chronIc Pain in neurOpathic patieNts (SENSATION)

Diabetic Neuropathies | Amputation | Neuropathy | Neuropathy, Painful | Sensory Neuropathy

Switzerland
University Hospital, Brest

Unknown

Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease (MASAÏ)

Primary sjögren's Syndrome

France
Watson Pharmaceuticals

Completed

Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome

Interstitial Cystitis | Painful Bladder Syndrome

United States
IRCCS Policlinico S. Matteo

Completed

Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome (IComaliz)

Interstitial Cystitis | Painful Bladder Syndrome

Italy
NYU Langone Health

Recruiting

The Natural History of Familial Dysautonomia

Hereditary Sensory and Autonomic Neuropathies | Familial Dysautonomia (Riley-Day Syndrome) | Hereditary Sensory and Autonomic Neuropathy 3

United States, Israel
Gazi University

Recruiting

Reliability, Validity of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire

Primary Sjögren's Syndrome

Turkey
University of Alabama at Birmingham
Washington University Early Recognition Center

Completed

Sensory Processing in Subjects With Painful Bladder Syndrome

Painful Bladder Syndrome

United States
Rambam Health Care Campus

Unknown

Identifying Predictors of Treatment Success in Painful Bladder Syndrome (PBS)

Painful Bladder Syndrome

Israel
Ain Shams University

Completed

Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome (PRP)

Interstitial Cystitis | Painful Bladder Syndrome (PBS)

Egypt
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome

China
University of Copenhagen
Rigshospitalet, Denmark; ITI Foundation; Gigtforeningen

Completed

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

Dental Implant | Primary Sjögren Syndrome
University of Rochester

Completed

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

Primary Sjögren Syndrome

United States
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Resolve Therapeutics

Not yet recruiting

A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome

Primary Sjögren Syndrome
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
David Sheyn

Not yet recruiting

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Interstitial Cystitis | Painful Bladder Syndrome | Painful Bladder Syndrome (PBS)
Ankara Education and Research Hospital

Completed

Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions

Primary Sjögren Syndrome

Turkey
University Hospital, Brest

Unknown

Eye Dryness Evaluation in Primary Sjögren's Syndrome (PEPSS)

Primary Sjögren Syndrome
Federal University of São Paulo

Completed

Resistance Exercise in Woman With Primary Sjörgen Syndrome.

Primary Sjögren Syndrome
Peking Union Medical College Hospital

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom

Clinical Trials on Primary Sjögren's Syndrome Painful Sensory Neuropathies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations